Public Calendar: September 8-14, 2024
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs
Event Date: 09/09/2024
Location: Washington, DC
Subject: Critical Path Institute Global Impact Conference; Panelist: Impact of Global Public-Private Collaborations on Drug Development
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, academia, industry, and other invited attendees
Event Date: 09/10/2024
Location: Boston, MA
Subject: Health Coverage Fellowship
FDA Participant/Group: MICHAEL FELBERBAUM;
Non FDA Participant/Group: Industry, government, academia, media, and other invited attendees
Event Date: 09/11/2024
Location: Washington, DC
Subject: 2024 Medical Device Innovation Consortium; Fireside Chat
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, media, and other registered attendees
Event Date: 09/11/2024
Location: Washington, DC
Subject: Samuel J. Heyman Service to America Medals Gala
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, government, and other invited guests
Event Date: 09/11/2024
Location: Washington, DC
Subject: Medical Device Shortages
FDA Participant/Group: HILARY MARSTON;
Non FDA Participant/Group: Jessica Johnston, Tom Polen (Becton, Dickinson and Company);
Event Date: 09/12/2024
Location: Silver Spring, MD
Subject: FDA Omics Day; Opening Remarks
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, and other invited guests
Event Date: 09/12/2024
Location: Virtual
Subject: SEMICON INDIA: Shaping the Semiconductor Future
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry and other registered attendees
Official Name: Namandjé N. Bumpus, Ph.D., Principal Deputy Commissioner
Event Date: 09/12/2024
Location: Virtual
Subject: Minority Health Equity and Reducing Health Disparities in Clinical Trials
FDA Participant/Group: WENDY SLAVIT; ANDREA FURIA-HELMS;
Non FDA Participant/Group: Sabrena Mervin-Blake (Clinical Trials Transformation Initiative (CTTI) from Duke University);
Official Name: Jim Jones, Deputy Commissioner for Human Foods
Event Date: 09/09/2024
Location: College Park, MD
Subject: Health and Chemical Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Members of the Health and Chemicals Coalition
Event Date: 09/13/2024
Location: Virtual
Subject: Highly Pathogenic Avian Influenza
FDA Participant/Group: STEVEN GRUBE;
Non FDA Participant/Group: Hilary Thesmar, Jennifer Hatcher, Leslie Sarasin, Stephanie Harris (Food Industry Association);
Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs
Event Date: 09/11/2024
Location: Virtual
Subject: Personal Care Products Council (PCPC) International Steering Commitee Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Francine Lamoriello, Natalie Obermann (Personal Care Products Council);
Event Date: 09/12/2024
Location: Washington, DC
Subject: Taste of Europe
FDA Participant/Group: N/A
Non FDA Participant/Group: H.E. Jovita Neliupsiene (Delegation of the European Union to the United States);
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy
Event Date: 09/10/2024
Location: San Jose, Costa Rica
Subject: Collaboration Opportunities
FDA Participant/Group: VESA VUNIQI; JOHN WEINER; MICHELLE RODRIGUEZ;
Non FDA Participant/Group: Alfonso Tenorio (Pan American Health Organization);
Event Date: 09/10/2024
Location: San Jose, Costa Rica
Subject: Regulatory Challenges Faced by Pharmaceutical and Medical Device Sectors in Costa Rica
FDA Participant/Group: JOHN WEINER; MICHELLE RODRIGUEZ; VESA VUNIQI;
Non FDA Participant/Group: Executives of Global Life-Centered Hub
Event Date: 09/10/2024
Location: San Jose, Costa Rica
Subject: Regulatory Convergence
FDA Participant/Group: JOHN WEINER; MICHELLE RODRIGUEZ; VESA VUNIQI;
Non FDA Participant/Group: Mary Munive Angermüller (Costa Rica Ministry of Health);
Official Name: Michael Rogers, Associate Commissioner for Regulatory Affairs
Event Date: 09/09/2024
Location: Washington, DC
Subject: Parenteral Drug Association (PDA) / FDA Joint Regulatory Conference 2024; Speaker: ORA Updates
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, regulatory, academia, and other stakeholders
Event Date: 09/10/2024
Location: Virtual
Subject: 2024 Association of American Feed Control Officials (AAFCO) / FDA Fall Briefing
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of the Association of American Feed Control Officials
Official Name: Leah Hunter, Associate Commissioner for External Affairs
No Significant Event
Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research
Event Date: 09/09/2024
Location: Washington, DC
Subject: Parenteral Drug Association (PDA) / FDA Joint Regulatory Conference 2024; Speaker: A Regulatory Perspective on Quality, Integrity, and FDA Modernization
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, regulatory, academia, and other stakeholders
Event Date: 09/09/2024
Location: Washington, DC
Subject: Critical Path Institute Global Impact Conference; Fireside Chat
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, academia, industry, and other invited attendees
Event Date: 09/12/2024
Location: Virtual
Subject: Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Paul Hudson (Sanofi);
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
Event Date: 09/09/2024
Location: Washington, DC
Subject: Parenteral Drug Association (PDA) / FDA Joint Regulatory Conference 2024; Speaker: CBER Updates
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, regulatory, academia, and other stakeholders
Event Date: 09/11/2024
Location: Washington, DC
Subject: Parenteral Drug Association (PDA) / FDA Joint Regulatory Conference 2024; Speaker: The Evolving Landscape of Biopharmaceutical Manufacturing
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, regulatory, academia, and other stakeholders
Event Date: 09/11/2024
Location: Washington, DC
Subject: Critical Path Institute Global Impact Conference; Panelist: Evidentiary Considerations for Drug Development Tools
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, academia, industry, and other invited attendees
Event Date: 09/12/2024
Location: Virtual
Subject: 4th Global Identification of Medicinal Products Working Group Technical and Stakeholders Meeting; Speaker: U.S. FDA Leadership Perspective
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, regulatory, academia, and other stakeholders
Event Date: 09/13/2024
Location: Bridgewater, NJ
Subject: BioNJ Maunfacturing Briefing 2024, Building the Future: Advancing Capabilities, Technology and Talent for the Next Era of Biomanufacturing; Speaker: Efforts at FDA to Facilitate Advanced Manufacturing
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, regulatory, academia, and other stakeholders
Official Name: Michelle Tarver, M.D., Ph.D., Acting Director, Center for Devices and Radiological Health
Event Date: 09/09/2024
Location: Menlo Park, CA
Subject: Medtech VISION Conference; Executive Interview
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other stakeholders
Event Date: 09/12/2024
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of AdvaMed's Technology and Regulatory Affairs Group
Event Date: 09/13/2024
Location: Virtual
Subject: CDRH / Medtronic Recurring Meeting Cadence
FDA Participant/Group: N/A
Non FDA Participant/Group: Laura Mauri (Medtronic);
Event Date: 09/13/2024
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Andrew Fish (Medical Device Innovation Consortium);
Event Date: 09/13/2024
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Scott Whitaker (AdvaMed);
Event Date: 09/13/2024
Location: Silver Spring, MD
Subject: Introductory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Laila Gurney (General Electric Healthcare);
Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition
Event Date: 09/09/2024
Location: Virtual
Subject: Fresh Produce Coalition Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several representatives of industry
Event Date: 09/10/2024
Location: Virtual
Subject: Food Program Regulatory Science Conference; Speaker: Opening Remarks
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, government, regulatory
Event Date: 09/11/2024
Location: Washington, DC
Subject: Items of Mutual Interest
FDA Participant/Group: KARI BARRETT; LAURA CARROLL;
Non FDA Participant/Group: Grant Leslie (FGS Global); Kerry Bridges, Laurie Schalow (Chipotle);
Official Name: Brian King, Ph.D., Director, Center for Tobacco Products
Event Date: 09/13/2024
Location: Schaumburg, IL
Subject: Convenience Store Products’ (CSP) Tobacco Forum 2024; Speaker: Updates on Tobacco Product Regulation in the United States
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, regulatory, and other stakeholders
Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine
Event Date: 09/12/2024
Location: Washington, DC
Subject: FDA Leadership Development Program Commencement Ceremony at American University
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia and other stakeholders
Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research
Event Date: 09/10/2024
Location: College Park, MD
Subject: Foods Program Regulatory Science Conference (FPRSC); Speaker: State of the Science
FDA Participant/Group: N/A
Non FDA Participant/Group: Government employees, academia, industry, and other stakeholders
Official Name: Mark Raza, J.D., Chief Counsel
No Significant Event